Work

Supplemental Tables S1-S3 from VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Tables S1-S3. Number/Frequency of mutations in 123 patients with lung cancer (S1); List of genes used in transcriptomic analysis (S2); Expression levels of VEGF-A in mutated (M) vs. wild-type (WT) TP53 lung cancer by histology (S3).

DOI: 10.1158/0008-5472.22408104

Authors: Maria Schwaederlé, Vladimir Lazar, Pierre Validire, Johan Hansson, Ludovic Lacroix, Jean-Charles Soria, Yudi Pawitan, Razelle Kurzrock

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361874797

Cites:

Cited by:

Related to: 10